Regulation - North America, Genito-urinary


Popular Filters

Watson gets FDA approval for generic Sanctura XR and Avapro


US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has received approval from the US Food and Drug…

AllerganAvaproCardio-vascularGenericsGenito-urinaryNorth AmericaRegulationSanctura XRSanofiWatson Pharmaceuticals

FDA approves Astellas' Myrbetriq for overactive bladder


The US Food and Drug Administration has approved Japanese drug major Astellas Pharma's (TYO: 4503) Myrbetriq…

Astellas PharmaGenito-urinarymirabegronMyrbetriqNorth AmericaPharmaceuticalRegulation

FDA advisory panel backs Astellas OAB drug mirabegron


The US subsidiary of Japanese drug major Astellas Pharma (TYO: 4503) said last week that the Reproductive…

Genito-urinarymirabegronNorth AmericaPharmaceuticalRegulation

Overactive bladder gel gets FDA nod


The US Food and Drug Administration (FDA) has approved US drugmaker Antares Pharma’s (NYSE Amex:…

Antares PharmaGenito-urinaryNorth AmericaOxybutyninPharmaceuticalRegulationWatson Pharmaceuticals

Back to top